Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
Thymosin Beta-4: Evidence Summary
Evidence summary for Thymosin Beta-4 across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.
Back to Thymosin Beta-4 overview| Indication | Evidence Tier | Trial Count | Summary |
|---|---|---|---|
| Corneal healing | Tier B | 2 | FDA-approved trials for neurotrophic keratitis show significant corneal repair |
| Wound healing | Tier C | 3 | Accelerates dermal and corneal wound healing in multiple small trials |
| Cardiac repair | Tier D | 1 | Preclinical data shows cardiomyocyte survival post-MI; human trials limited |